The ¡°Obesity Paradox? Does It Persist Among Israeli Patients With Decompensated Heart Failure? A Subanalysis of the Heart Failure Survey in Israel (HFSIS)

详细信息    查看全文

• 作者：Shmuel Schwartzenberg ; MD¹ ; Michal Benderly ; PhD² ; Stephen Malnick ; MD¹ ; Jacob George ; MD¹ ; Sorel Goland ; MD¹ ; ^{sorel_g@clalit.org.il}
• 关键词：Obesity paradox ; reverse epidemiology ; congestive heart failure
• 刊名：Journal of Cardiac Failure
• 出版年：2012
• 出版时间：January 2012
• 年：2012
• 卷：18
• 期：1
• 页码：62-67
• 全文大小：272 K

文摘

Background

Earlier studies among heart failure (HF) patients reported a paradox of reduced mortality rates in those with increased body mass index (BMI). Recently, however, it has been shown that obesity was not associated with better prognosis in certain groups. The aim of this study was to evaluate the ¡°obesity paradox?among patients included in the Heart Failure Survey in Israel (HFSIS).

Methods and Results

Clinical, demographic, and laboratory characteristics of 2,323 patients hospitalized with a diagnosis of acute or decompensated chronic HF in 25 public Israeli hospitals between March 1 and April 30, 2003, were categorized by BMI as: normal weight (18.5-24.9 kg/m²; n?= 837), overweight (25.0-29.9 kg/m²; n?= 877), or obese (?0.0 kg/m²; n?= 574), excluding 35 patients with BMI <18.5?kg/m². Survival over 15 months was inversely related to BMI category. Age-adjusted mortality hazard ratio (HR) was 0.95 (95 % confidence interval [CI] 0.79-1.14) for overweight patients and 0.70 (95 % CI 0.55-0.88) for obese patients compared with normal-weight patients. After further adjustment for gender, ejection fraction, New York Heart Association functional class, ischemic heart disease, diabetes, hypertension, dyslipidemia, renal function, and medications (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, ¦Â-blocker, spironolactone), obesity was associated with a nonsignificant HR of 0.79 (95 % CI 0.59-1.05). Hypertension and dyslipidemia were also paradoxically associated with better survival in our model (HR 0.74, CI 0.59-0.92; and HR 0.77, CI 0.63-0.94; respectively; both P < .05).

Conclusions

Our study falls in line with the obesity paradox observation (in obese but not overweight patients) in a large survey of HF patients, although this finding was not statistically significant on multivariate adjustment analysis.